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The etiology of the rheumatoid factors in patients with rheumatoid arthritis and of anti-globulin antibodies
in normal individuals remains obscure
despite recently documented observations. Allen and Kunkel (1963) and
Vierucci (1965) have reported an increased incidence of anti-globulin
antibodies in children who received
multiple transfusions for chronic anemia. Fudenberg et al. (1964) and
Stiehm (1965) found that children who
had been receiving repeated y-globulin
injections were more prone to produce
anti-globulin antibodies than children
not exposed to y-globulin. These data
furnish indirect evidence of the isoantigenicity of genetic determinants in
human y-globulin. From the clinical
standpoint, the observations are of interest to pediatricians administering
y-globulin to children whose sera show
low levels of y-globulin, and whose
clinical courses are characterized by
repeated or chronic infections.
This study was undertaken to determine the incidence of anti-globulin
antibodies in non-hospitalized children
with chronic or recurrent upper respiratory infections, only some of
whom had received y-globulin injections.
Materials and Methods

The 185 children studied were under
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the care of their private physicians or
attended the pediatric clinic. Hospital
patients were not included. With the
cooperation of the participating physicians, history forms were completed on
each child, recording age, race, sex,
the amount and duration of globulin
therapy, reason for administering yglobulin, transfusion history, and
whether or not joint symptoms were
present. All children with a transfusion
history were excluded from this study
in order to obtain a more uniform
population.
The 44 children who had received
y-globulin injections had y-globulin
levels less than 500 mg per 100 ml.
The duration of y-globulin therapy reflected to some degree the course and
duration of their respiratory infections.
The 141 children who had "never" rereceived any y-globulin comprised the
largest group. Although these children
were recorded as "never" having had
y-globulin, it has been customary for
some physicians to give a small amount
of y-globulin with measles vaccine.
Some of these 141 children were tested
before the initiation of y-globulin
therapy. Thus, these children do not
necessarily represent a group of children with normal levels of y-globulin.
All sera were tested at a 1 : 20 dilution by: the slide latex test (Hyland),
the sensitized human cell test, and the
sensitized sheep cell test. These tests
have been described previously (Waller
et al., 1961). In addition, most of the
sera were tested at a 1 : 5 dilution with
selected sensitized cells known to detect anti-Gm", Gm", Gmx and Gm'
activity.
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Results
100

Anti-globulin Antibodies
Of the 185 children studied, only 44
had received injections of y-globulin
at the time of testing. All of these children were tested at a 1 : 20 dilution of
their serum with the slide latex test
and the sensitized human cell test. The
latex test was strongly reactive in only
one child and weakly reactive in 12
children. Only one of these 13 children
had received y-globulin injections. The
human cell test was positive in eight
children (4.3 % ), only one of whom had
received y-globulin. This incidence does
not differ significantly from that characteristic of the normal adult population (Waller et al. , 1964). The sensitized sheep cell test (Waaler-Rose
Test) was performed on 135 children,
including all children found to be positive by any of the other tests. In no
instance was a positive sheep cell test
observed.
Since the titers of anti-globulin antibodies in normal individuals may often
fall below 1 : 20, 140 of the original
185 children were tested at 1 : 5 dilution of their serum with Ripley sensitized cells. Eighteen children (12.9 % )
gave positive tests at this dilution. However, of these 18 children with positive
tests, only three had received injections
of y-globulin.
Thus, to look at the results in another way, of the 108 children who had
not received injections of y-globulin
and whose sera were tested at a 1 : 5
dilution, 15 (13.9 %) gave positive
tests. However, of the 32 children who
had received y-globulin and whose
sera were tested at a 1 : 5 dilution, only
three (9.4 %) gave positive tests. These
differences are probably not statistically significant (p > .4).
Figure 1 compares the titers of antiglobulin antibodies in children who
h ad received y-globulin injections with
those who had not received any yglobulin. The left bars, 1 : 5, represent
the negative group in our study, since
the children were not tested at a level
below 1: 5. Ten children gave titers of
1 :5, but only two of these had had
y-globulin. Eight children had titers
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Fig. 1-Titers of anti-globulin antibodies in 32 children who had received '}'-globulin
injections, and 108 who had not.

above 1 :5, but only one child had had
y-globulin. Thus, among the 44 children who had received injections of
y-globulin, only three children gave
positive tests for anti-globulin antibodies. There was no correlation between the amount of y-globulin administered , the duration of globulin
therapy, and the presence of a positive test for anti-globulin antibodies .
Three children had had in excess of
100 m l of y-globulin over a period
from one to three years, and all gave
negative tests at 1 : 20 dilution of their
serum. Two of the three were also
negative at 1 : 5 dilution of their serum.

Gm Specificity
Antibodies

of

Anti-globulin

In addition to the sensitized human
cell test (Ripley), four other anti-D
sera were used to sensitize cells for Gm
specificity of the children's sera. Ninety
children were tested for Gm specificity.
Of these 90 children, 10 agglutinated
the Ripley sensitized cells and five of
the 10 agglutinated one or more of
the other sensitized cells. Of these 10
children, five gave specific anti-Gm
activity, one anti-Gm(f), one antiGm(x) , and three anti-Gm(a). The
sera of the other five children agglu27
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tinated only the Ripley sensitized cells,
and it was not possible to obtain Gm
specificity. Of the five children whose
sera showed specific anti-Gm activity,
only one had received y-globulin.

Lack of Correlation between Presence of Anti-globulin Antibodies and
Level of y-globulin or Age of Children
There was no apparent correlation
between the presence of hypogammaglobulinemia (<500 mg per 100 ml)
and the presence of anti-globulin antibody. There was also no correlation
between the ages of the children and
the presence of anti-globulin antibody.
Among the children up to three years
of age, 12% gave positive tests for
anti-globulin antibody at a 1 : 5 dilution of their sera. Among the children
over three years of age, 13 .7 % gave
positive tests. Of the 185 children
studied, four children gave history of
joint complaints, none had had y-globulin at the time of the study, and none
had anti-globulin antibodies demonstrable in their sera.

Injection of y-Globulin into Adults
We have studied the effects of subcutaneous injections of pooled y-globulin in four young healthy male volunteers. These men were all Gm(a-)
and received (.5 ml) injections of pooled
y-globulin weekly. In addition to tests
for anti-globulin antibodies, slide latex
tests, and sensitized sheep cell tests, the
followi ng tests were performed: serum
electrophoretic pattern, sedimentation
rate, hemoglobin , and total protein.
Two of the volunteers received a
total of eight injections of y-globulin
over a period of three months and two
received 16 injections over a period of
one year. In no instance did these four
individuals produce anti-globulin antibodies, nor were any changes noted in
the other tests performed.
Discussion

Although the incidence of anti-globulin antibodies in children receiving
multiple transfusions is markedly increased, we were not able to demonstrate this increased incidence in the
28

children receiving pooled y-globulin.
There are several possible explanations
for these observed differences. The
children receiving multiple transfusions
had a definite disease entity while the
children that we studied were "normal"
except for chronic or recurrent upper
respiratory infections. The evaluation
of just how chronic, recurrent, or severe the infection rested with the individual physician; however, all of the
children studied had electrophoretic
patterns of their serum performed as
a consequence of the degree or duration of their infection. No attempt was
made in this study to separate the
children according to degree or duration of their illnesses. Certainly, the
children were not ill enough to require
hospitalization during the period of
this study.
It is possible that plasma is more
antigenic than pooled y-globulin or
that the globulin administered intravenously is a better antigen than when
it is administered intramuscularly. In
addition, the children receiving multiple transfusions received more plasma
for a longer period of time than did
the children receiving pooled y-globulin.
Stiehm and Fudenberg (1965) studied 14 hypogammaglobulinemic children who had received many y-globulin injections and found that nine of
these children (64.3 % ) had developed
anti-globulin antibodies. Among the
24 untreated siblings of these children,
only two agglutinators were found
(8 .3% ). We are not able to explain the
discrepancies in these results other
than by the fact that we did not use as
controls the siblings of the hypogammaglobulinemic children. However, in
addition , one may presume that the
untreated siblings were untreated because they were not hypogammaglobulinemic or that they were not
subject to chronic or recurrent infection. Some of our untreated children
were hypogammaglobulinemic and
most were subject to chronic infection.
After the testing of their sera, some
children were started on y-globulin
therapy.
Since an equal number of our children who had not received y-globulin
produced anti-globulin antibodies, pre-
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sumably other, as yet unknown, agents
are as likely to stimulate the production of these antibodies as is the administration of pooled y-globulin.
Steinberg and Wilson (1963) studied
eight non-transfused donors of yglobulin antibodies a nd found that in
each instance the donor's mother had
the globulin factor that the donor
lacked. They assumed that the donor's
antibody was formed as a result of
transplacental isoimmunization. However, we have been unsuccessful in our
attempts to elicit anti-globulin antibodies in normal adult Gm(a-) volunteers by the injection of pooled yglobulin.
There is no definitive evidence that
the serological reactions called rheumatoid factors in patients with rheumatoid arthritis and anti-globulin antibodies in normal individuals, differ
except in strength of reaction (titer)
and possibly in specificity. Not all investigators are convinced that the idea
of an antigen-antibody relationship for
y-globulin (Gm) and anti-globulin reagents (anti-Gm) in man is firmly established (Grubb, 1961). Certainly,
the deleterious effects of the serological reactions called "rheumatoid factors" have not been proven at the
present time. Regardless of these unresolved questions, it is not established
that the isoantigenicity of y-globulin
is such as to override its therapeutic
potential in infection.
Summary

for sending us some of his young patients who had been on long-term
y-globulin therapy. We also thank Miss
Jane Atkinson for providing us with
m ost of the sera used in this study.
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1. We examined sera from 185 nonhospitalized children, 44 of whom had
received repeated injections of y-globulin for upper respiratory infections.
2. There was no significant difference in the incidence of anti-globulin
antibodies in the two groups.
3. The presence of anti-globulin
antibodies could not be correlated with
the level of y-globulin in the children's
sera or with the age of the children.
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